Shufang Wang

发表

YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial

Hui Liu, C. Yao, Jun Zhu, 2021, Frontiers in Medicine.

Clinical effects of cisplatin plus recombinant human endostatin (rh-endostatin) intratumoral injection on malignant central airway obstruction: a retrospective analysis of 319 cases

N. Zhang, Nan Zhang, Shufang Wang, 2021, Journal of thoracic disease.

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic evaluation of YF-H-2015005 for mobilizing Hematopoietic stem cells in Non-Hodgkin's Lymphoma Patients

Jun Zhu, Yi-min Cui, Weiping Liu, 2020, Journal of Cancer.

Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy

J. Mendell, P. Shieh, C. McDonald, 2023, Frontiers in cell and developmental biology.